Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
📡
Tech
Articles similaires
Tech
Ricursive Intelligence is betting on AI-designed chips to help solve the compute crisis
The founders detailed how their startup is developing AI that can design chips, learn from each iteration, and improve subsequent designs, all with the goal of automating and accelerating the chip design process.
Tech
Flock CEO defends surveillance technology amid national backlash: ‘We shouldn’t pause progress’
At TechCrunch Disrupt, Flock CEO Garrett Langley defended his company's surveillance technology despite growing privacy concerns, arguing that its crime-fighting benefits outweigh the risks of abuse.
Tech
Meet the five companies competing in the Startup Battlefield finals at Disrupt 2026
It’s time to unveil the five companies that will be competing in the Startup Battlefield finals.
Commentaires (0)
Aucun commentaire pour le moment. Soyez le premier à réagir.
Laisser un commentaire